study_id	fasta_header_name	fasta_file_name	isolate_id	specimen_collector_sample_id	biosample_accession	sra_accession	case_identifier	geo_loc_name_country	geo_loc_name_state_province_territory	geo_loc_name_city	destination_of_most_recent_travel_(country)	most_recent_departure_date	sample_collected_by	sample_collection_date	sample_receive_date	specimen_source_material_category	biospecimen	collection_device	geo_loc_latitude	geo_loc_longitude	purpose_of_sampling	subject_age_at_time_of_specimen_collection	subject_age_unit	subject_sex	subject_disease_outcome	vaccination_status	number_of_vaccine_doses_received	date_of_last_vaccine_dose	nucleic_acid_extraction_method	purpose_of_sequencing	sequencing_date	sequencing_instrument	sequencing_depth	median_read_depth	sequence_assembly_software_name	sequence_assembly_software_version	reference_genome_accession	assembly_genome_size	consensus_genome_length	n50	percentage_gc	serogroup	serotype	lineage_name	plasmid_identified	sequence_typing_method	sequence_type	virulence_factor_genes	other_virulence_factor_gene	resistance_genes	azithromycin_resistance_phenotype	chloramphenicol_resistance_phenotype	trimethoprim_sulfamethoxazole_resistance_phenotype	sulfinamides_resistance_phenotype	ampicillin_resistance_phenotype	ciprofloxacin_resistance_phenotype
CDC-01	CP078901.1 Vibrio cholerae strain VC2024A chromosome 1	CP078901.1 Vibrio cholerae strain VC2024A chromosome 1	VibrioCholerae_VC2024A_CP078901.1	CP078901	SAMN25678901	SRS7890123	VC-UG-20240815-001	Uganda	Agago	Kampala	Colombia	2024-08-10	CDC	2024-08-15	2024-08-16	Human Clinical Specimen	Stool	Collection Container	23.8103 N	90.4125 E	Diagnostic Testing	32	Years	Female	Recovered	Fully Vaccinated	2	2024-06-20	Qiagen QIAamp DNA Stool Mini Kit	Priority Surveillance Project	2024-08-18	Illumina NextSeq	80x	75x	SPAdes	3.15.4	CP078901	3 012 456 bp	3 012 234 bp	3,012,456 bp	48%	Vibrio cholerae O1	Ogawa	T13	IncC	MLST	ST515	ctxA	tcpA	strA	Susceptible Dose Dependent Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype
WHO-02	CP089234.1 Vibrio cholerae strain KN2024B chromosome 1	CP089234.1 Vibrio cholerae strain KN2024B chromosome 1	VibrioCholerae_KN2024B_CP089234.1	CP089234	SAMN26789012	SRS8901234	VC-SA-20240722-002	South Africa	KwaZulu-Natal	Durban	Fiji	2024-07-15	WHO	2024-07-22	2024-07-23	Human Clinical Specimen	Rectal Swab	Swab	1.2867 S	36.8172 E	Missing	45	Years	Male	Deteriorating	Not Vaccinated	0		Phenol-Chloroform Extraction	Priority Surveillance Project	2024-07-25	PacBio Sequel II	100x	95x	Canu	2.2	CP089234	2 987 654 bp	2 987 432 bp	2,987,654 bp	47%	Vibrio cholerae O1	Inaba	T12	IncA/C	MLST	ST69	ctxB	zot	tetA	Intermediate Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype
NICD-03	CP090567.1 Vibrio cholerae strain MZ2024C chromosome 1	CP090567.1 Vibrio cholerae strain MZ2024C chromosome 1	VibrioCholerae_MZ2024C_CP090567.1	CP090567	SAMN27890123	SRS9012345	VC-EG-20240903-003	Egypt	Qina		Algeria	2024-08-28	NICD	2024-09-03	2024-09-04	Environmental Specimen	Bacterial Isolate	Swab			Research			Missing			Qiagen DNeasy Blood & Tissue Kit	Priority Surveillance Project	2024-09-06	Illumina MiSeq	50x	45x	MEGAHIT	1.2.9	CP090567	3 123 789 bp	3 123 567 bp	3,123,789 bp	46%	Vibrio cholerae O139		T15	None	MLST	ST250	ace	ompU	catA	Susceptible Dose Dependent Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype
IPD-04	CP091890.1 Vibrio cholerae strain HT2024D chromosome 1	CP091890.1 Vibrio cholerae strain HT2024D chromosome 1	VibrioCholerae_HT2024D_CP091890.1	CP091890	SAMN28901234	SRS0123456	VC-UG-20240810-004	Uganda	Agago	Gulu	Colombia	2024-08-05	IPD	2024-08-10	2024-08-11	Human Clinical Specimen	Stool	Collection Container	18.5944 N	72.3074 W	Diagnostic Testing	8	Years	Female	Recovered	Partially Vaccinated	1	2024-07-01	PowerSoil DNA Isolation Kit	Screening for Variants of Concern (VoC)	2024-08-13	Oxford Nanopore GridION	70x	65x	Flye	2.9	CP091890	2 876 543 bp	2 876 321 bp	2,876,543 bp	48%	Vibrio cholerae O1	Ogawa	T13	IncF	MLST	ST515	ctxA	tcpA	dfrA1	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype
MSF-05	CP092123.1 Vibrio cholerae strain YE2024E chromosome 1	CP092123.1 Vibrio cholerae strain YE2024E chromosome 1	VibrioCholerae_YE2024E_CP092123.1	CP092123	SAMN29012345	SRS1234567	VC-SA-20240915-005	South Africa	KwaZulu-Natal		Fiji	2024-09-10	MSF	2024-09-15	2024-09-16	Human Clinical Specimen	Stool	Collection Container	15.3694 N	44.1910 E	Diagnostic Testing	28	Years	Male	Deceased	Not Vaccinated	0		Qiagen QIAamp DNA Stool Mini Kit	Priority Surveillance Project	2024-09-18	Illumina HiSeq	90x	85x	Unicycler	0.5.0	CP092123	2 998 765 bp	2 998 543 bp	2,998,765 bp	47%	Vibrio cholerae O1	Hikojima	T12	IncA/C	MLST	ST69	ctxA	rtxA	sul2	Intermediate Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype
PAHO-06	CP093456.1 Vibrio cholerae strain PE2024F chromosome 1	CP093456.1 Vibrio cholerae strain PE2024F chromosome 1	VibrioCholerae_PE2024F_CP093456.1	CP093456	SAMN30123456	SRS2345678	VC-EG-20240825-006	Egypt	Qina		Algeria	2024-08-20	PAHO	2024-08-25	2024-08-26	Human Clinical Specimen	Rectal Swab	Swab	12.0464 S	77.0428 W	Missing	19	Years	Female	Recovered	Fully Vaccinated	2	2024-07-15	Phenol-Chloroform Extraction	Screening for Variants of Concern (VoC)	2024-08-28	PacBio Sequel II	110x	105x	HGAP	4.0	CP093456	3 045 678 bp	3 045 456 bp	3,045,678 bp	46%	Vibrio cholerae O1	Inaba	T14	None	MLST	ST171	ctxB	hlyA	floR	Susceptible Dose Dependent Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype
ECDC-07	CP094789.1 Vibrio cholerae strain IN2024G chromosome 1	CP094789.1 Vibrio cholerae strain IN2024G chromosome 1	VibrioCholerae_IN2024G_CP094789.1	CP094789	SAMN31234567	SRS3456789	VC-UG-20240905-007	Uganda	Agago		Colombia	2024-09-01	ECDC	2024-09-05	2024-09-06	Environmental Specimen	Bacterial Isolate	Swab			Research			Missing			Qiagen DNeasy Blood & Tissue Kit	Screening for Variants of Concern (VoC)	2024-09-08	Illumina NextSeq	75x	70x	SPAdes	3.15.4	CP094789	2 956 789 bp	2 956 567 bp	2,956,789 bp	48%	Vibrio cholerae O1	Ogawa	T13	IncC	MLST	ST515	ctxA	tcpA	ermB	Resistant Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype
AFRIMS-08	CP095012.1 Vibrio cholerae strain TH2024H chromosome 1	CP095012.1 Vibrio cholerae strain TH2024H chromosome 1	VibrioCholerae_TH2024H_CP095012.1	CP095012	SAMN32345678	SRS4567890	VC-SA-20240920-008	South Africa	KwaZulu-Natal	Cape Town	Fiji	2024-09-15	AFRIMS	2024-09-20	2024-09-21	Human Clinical Specimen	Stool	Collection Container	13.7563 N	100.5018 E	Diagnostic Testing	52	Years	Male	Recovered	Partially Vaccinated	1	2024-08-30	PowerSoil DNA Isolation Kit	Priority Surveillance Project	2024-09-23	Oxford Nanopore PromethION	95x	90x	Raven	1.8	CP095012	3 078 901 bp	3 078 679 bp	3,078,901 bp	47%	Vibrio cholerae O139		T15	IncF	MLST	ST250	ace	ompW	qnrVC	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Resistant Antimicrobial Phenotype
PHAC-09	CP096345.1 Vibrio cholerae strain NG2024I chromosome 1	CP096345.1 Vibrio cholerae strain NG2024I chromosome 1	VibrioCholerae_NG2024I_CP096345.1	CP096345	SAMN33456789	SRS5678901	VC-EG-20240930-009	Egypt	Qina	Cairo	Algeria	2024-09-25	PHAC	2024-09-30	2024-10-01	Human Clinical Specimen	Rectal Swab	Swab	6.5244 N	3.3792 E	Missing	37	Years	Female	Deteriorating	Not Vaccinated	0		Qiagen QIAamp DNA Stool Mini Kit	Priority Surveillance Project	2024-10-03	Illumina MiSeq	60x	55x	Velvet	1.2.10	CP096345	2 945 678 bp	2 945 456 bp	2,945,678 bp	48%	Vibrio cholerae O1	Hikojima	T12	IncA/C	MLST	ST69	ctxA	rtxC	aadA1	Susceptible Dose Dependent Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype
USCDC-10	CP097678.1 Vibrio cholerae strain PH2024J chromosome 1	CP097678.1 Vibrio cholerae strain PH2024J chromosome 1	VibrioCholerae_PH2024J_CP097678.1	CP097678	SAMN34567890	SRS6789012	VC-UG-20241005-010	Uganda	Agago	Kasese	Colombia	2024-10-01	USCDC	2024-10-05	2024-10-06	Human Clinical Specimen	Stool	Collection Container	14.5995 N	120.9842 E	Diagnostic Testing	14	Years	Male	Recovered	Fully Vaccinated	2	2024-09-10	Phenol-Chloroform Extraction	Screening for Variants of Concern (VoC)	2024-10-08	PacBio Sequel II	120x	115x	Canu	2.2	CP097678	3 089 012 bp	3 088 790 bp	3,089,012 bp	46%	Vibrio cholerae O1	Inaba	T14	IncC	MLST	ST171	ctxB	hlyA	blaCTX-M	Resistant Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Susceptible Dose Dependent Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype	Resistant Antimicrobial Phenotype	Intermediate Antimicrobial Phenotype